Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.6640
+0.0096 (1.47%)
At close: Jan 23, 2026, 4:00 PM EST
0.6507
-0.0133 (-2.00%)
After-hours: Jan 23, 2026, 7:17 PM EST
Purple Biotech Employees
Purple Biotech had 9 employees as of December 31, 2024. The number of employees decreased by 11 or -55.00% compared to the previous year.
Employees
9
Change (1Y)
-11
Growth (1Y)
-55.00%
Revenue / Employee
n/a
Profits / Employee
-$361,222
Market Cap
7.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 9 | -11 | -55.00% | 9 | 0 |
| Dec 31, 2023 | 20 | 0 | - | 20 | 0 |
| Dec 31, 2022 | 20 | 1 | 5.26% | 20 | 0 |
| Dec 31, 2021 | 19 | 6 | 46.15% | 19 | 0 |
| Dec 31, 2020 | 13 | 4 | 44.44% | 13 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Theriva Biologics | 22 |
| Genprex | 15 |
| Indaptus Therapeutics | 7 |
| Adial Pharmaceuticals | 5 |
| Acurx Pharmaceuticals | 4 |
| 60 Degrees Pharmaceuticals | 3 |
| Xenetic Biosciences | 2 |
| Alaunos Therapeutics | 1 |
PPBT News
- 7 weeks ago - Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress - GlobeNewsWire
- 2 months ago - Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform - GlobeNewsWire
- 3 months ago - Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewsWire
- 5 months ago - Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants - GlobeNewsWire
- 5 months ago - Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 months ago - Purple Biotech Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025 - GlobeNewsWire